(Q45120831)

9 December 2017

Platelet uptake of GABA and glutamate in patients with bipolar disorder (English)

1 reference

9 December 2017

1 reference

2

1 reference

9 December 2017

10

1 reference

9 December 2017

Marianna Abelli

3

0 references

Stefano Pini

object named as

Stefano Pini

5

0 references

Lisa Lari

7

object named as

Lisa Lari

1 reference

9 December 2017

4

Anna Panighini

1 reference

9 December 2017

Simona Daniele

1

1 reference

9 December 2017

Camilla Gesi

6

1 reference

9 December 2017

Alessandra Cardini

8

1 reference

9 December 2017

Giovanni Battista Cassano

9

1 reference

9 December 2017

1 May 2012

1 reference

9 December 2017

1 reference

9 December 2017

14

1 reference

9 December 2017

3

1 reference

9 December 2017

301-308

1 reference

Neurotransmitter transporters: molecular function of important drug targets

9 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.01005.X

Presynaptic glutamatergic dysfunction in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.01005.X

Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: a decade of advance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.01005.X

Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.01005.X

The GABAergic deficit hypothesis of major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.01005.X

Metabotropic glutamate receptors: physiology, pharmacology, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.01005.X

Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.01005.X

GABA transporters as drug targets for modulation of GABAergic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.01005.X

GABA transporter heterogeneity: pharmacology and cellular localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.01005.X

Cloning and expression of a betaine/GABA transporter from human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.01005.X

Uptake of Taurine, GAB A, 5-HT, and Dopamine by Blood Platelets in Progressive Myoclonus Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.01005.X

Increased expression of the neuronal glutamate transporter (EAAT3/EAAC1) in hippocampal and neocortical epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.01005.X

Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.01005.X

Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.01005.X

Dysregulation of GABAergic neurotransmission in mood disorders: a postmortem study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.01005.X

Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.01005.X

Reduced anxiety and depression-like behaviors in mice lacking GABA transporter subtype 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.01005.X

Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.01005.X

Beyond monoamines: glutamatergic function in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.01005.X

Prominent reduction in pyramidal neurons density in the orbitofrontal cortex of elderly depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.01005.X

GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.01005.X

Age-dependent reductions in the level of glial fibrillary acidic protein in the prefrontal cortex in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.01005.X

GABA and mood disorders: a brief review and hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.01005.X

Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.01005.X

The human platelet as a model for the glutamatergic neuron: platelet uptake of L-glutamate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.01005.X

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.01005.X

A rating scale for mania: reliability, validity and sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.01005.X

Glutamatergic mechanisms in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.01005.X

Glutamate receptor genes: susceptibility factors in schizophrenia and depressive disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.01005.X

Hypomania: hype or mania?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.01005.X

Long-term anxiolytic and antidepressant-like behavioural effects of tiagabine, a selective GABA transporter-1 (GAT-1) inhibitor, coincide with a decrease in HPA system activity in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.01005.X

Tiagabine in treatment refractory bipolar disorder: a clinical case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.01005.X

10.1111/J.1399-5618.2012.01005.X

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference